Selank

What is Selank?

Selank (TP-7) is a synthetic heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is an analog of the naturally occurring immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg), extended with a Pro-Gly-Pro sequence that dramatically increases its stability and half-life. Selank was approved in Russia in 2009 as a nasal spray for the treatment of generalized anxiety disorder and as a nootropic agent.

The anxiolytic mechanism of Selank involves modulation of the GABAergic system and monoamine neurotransmitter pathways. Research has shown that Selank increases BDNF (brain-derived neurotrophic factor) expression in the hippocampus, modulates the balance of T-helper 1 and T-helper 2 cytokines, influences serotonin metabolism by affecting tryptophan hydroxylase expression, and stabilizes enkephalin levels in the blood [2]. Unlike benzodiazepines, Selank does not cause sedation, cognitive impairment, or dependence.

The nootropic properties of Selank have been demonstrated in animal models showing improved learning and memory formation, particularly under conditions of stress. Gene expression studies reveal that Selank affects the expression of 36 genes in the hippocampus, many related to neuronal plasticity, signal transduction, and neurotransmitter regulation [3]. The compound also exhibits significant immunomodulatory activity, influencing IL-6, TNF-alpha, and interferon expression, reflecting its tuftsin-derived heritage.

Mechanism of Action

Selank's anxiolytic and nootropic effects arise from a multifaceted interaction with several neurochemical systems, distinct from conventional anxiolytics:

GABAergic Modulation

Selank modulates the GABAergic system without directly binding to GABA-A receptors in the manner of benzodiazepines. Instead, it influences GABA metabolism and receptor sensitivity, producing anxiolytic effects without the sedation, tolerance, or withdrawal associated with direct GABA-A agonists. This mechanism makes Selank functionally anxiolytic while preserving alertness and cognitive function [1].

BDNF & Neuroplasticity

Selank upregulates BDNF expression in the hippocampus and prefrontal cortex. BDNF is a key mediator of synaptic plasticity, long-term potentiation, and neuronal survival. Increased BDNF levels are associated with improved learning, memory consolidation, and resilience to stress-induced neuronal damage. This mechanism likely underlies Selank's nootropic properties [3].

Serotonin & Enkephalin Systems

Research demonstrates that Selank influences serotonin metabolism through modulation of tryptophan hydroxylase expression, the rate-limiting enzyme in serotonin synthesis. Additionally, Selank stabilizes enkephalin levels in the blood, preventing their rapid enzymatic degradation. Enkephalins are endogenous opioid peptides involved in mood regulation and stress adaptation. This dual action on serotonergic and opioidergic systems contributes to the compound's anxiolytic profile.

Immunomodulatory Activity

Reflecting its tuftsin heritage, Selank modulates immune function through effects on cytokine expression. It has been shown to influence the balance of pro-inflammatory (Th1) and anti-inflammatory (Th2) cytokines, normalize IL-6 and TNF-alpha levels, and enhance antiviral interferon expression [4]. These immunomodulatory effects operate independently of the anxiolytic mechanism and may contribute to improved well-being during periods of psychological stress.

Dosing Protocol

Selank can be administered intranasally or subcutaneously. The intranasal route is most commonly used in approved Russian clinical practice and provides rapid absorption through the nasal mucosa.

Reconstitution Guide

Reconstitute lyophilized Selank with bacteriostatic water. The Pro-Gly-Pro extension provides better stability than native tuftsin. For intranasal use, the reconstituted solution is transferred to a nasal spray device.

1. Remove the plastic cap from the Selank vial and wipe the rubber stopper with an alcohol swab. Allow to dry.
2. Draw 2 mL of bacteriostatic water into a sterile syringe. For a 5 mg vial, this yields a concentration of 2,500 mcg/mL.
3. Insert the needle through the rubber stopper at a slight angle. Inject the water slowly against the inner wall of the vial — do not spray directly onto the peptide powder.
4. Allow the vial to sit for 1–2 minutes. Gently roll the vial between your palms if needed. Do not shake or vortex.
5. The solution should be completely clear and colorless. Discard if you observe any cloudiness, particulate matter, or discoloration.

Injection Technique

Selank can be administered subcutaneously (SubQ) or intranasally. For SubQ injection, follow standard peptide injection technique.

1. Clean the injection site with an alcohol swab and allow it to air dry completely (approximately 30 seconds). Common sites: lower abdomen (2 inches from the navel), upper thigh, or upper outer arm.
2. Draw the dose. Insert the needle into the vial through the rubber stopper. Invert the vial and draw the calculated number of units slowly. Tap the syringe to move any air bubbles to the top, then push them out gently.
3. Pinch the skin at the injection site to create a fold of subcutaneous tissue. Insert the needle at a 45-degree angle in a quick, smooth motion. Release the skin fold.
4. Inject slowly. Depress the plunger steadily over 5–10 seconds. Withdraw the needle at the same angle it was inserted. Apply gentle pressure with a clean swab if needed.

Storage & Stability

Selank benefits from its Pro-Gly-Pro extension, which provides better enzymatic stability than native tuftsin. Proper storage practices remain essential.

Side Effects & Considerations

Selank has been well-tolerated in Russian clinical use since its approval in 2009, with a safety profile that compares favorably to benzodiazepines and SSRIs.

Commonly Reported

• Mild nasal irritation — with intranasal administration; transient stinging or dryness. Usually resolves within minutes.
• Mild fatigue — reported in some individuals at higher doses, particularly during the first few days of use.
• Slight changes in appetite — both increase and decrease have been reported anecdotally.

Theoretical Considerations

• No sedation, cognitive impairment, or withdrawal effects have been documented — a significant advantage over benzodiazepine anxiolytics.
• No dependency or tolerance development reported in clinical or preclinical studies.
• Immunomodulatory effects may not be desired in all research contexts; individuals with autoimmune conditions should exercise caution.
• Clinical data is predominantly from Russian researchers; independent Western replication is limited but growing.

Stacking Protocols

Selank is frequently studied alongside other nootropic peptides, particularly Semax. The two compounds have complementary mechanisms and are often combined in research protocols.

Selank + Semax (Nootropic Stack)

The most common nootropic peptide combination. Selank provides anxiolytic and mood-stabilizing effects while Semax delivers cognitive enhancement and neuroprotection. The two peptides share the same Pro-Gly-Pro stabilizing extension but act through different receptor systems.

Lifestyle Factors

Research suggests the following complementary practices may support Selank's anxiolytic and cognitive effects:

• Mindfulness and stress reduction: Selank's anxiolytic effects may be enhanced by concurrent stress management practices including meditation, deep breathing, and regular exercise.
• Sleep quality: Adequate sleep supports BDNF production and memory consolidation, complementing Selank's neuroplasticity-enhancing effects.
• Omega-3 fatty acids: DHA and EPA support neuronal membrane fluidity and BDNF signaling, potentially enhancing nootropic benefits.
• Cognitive training: Combining Selank with structured learning or cognitive exercises may maximize the neuroplasticity window created by increased BDNF expression.

Related Peptides

Researchers studying Selank often investigate these related compounds:

Literature & Citations

1. Zozulya AA, Gabaeva MV, Sokolov OY, et al. Personality, coping style, and constitutional neuroimmunology. J Immunotoxicol. 2008;5(2):221-225. PubMed
2. Kozlovskii II, Danchev ND. The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats. Neurosci Behav Physiol. 2003;33(7):639-643. PubMed
3. Semenova TP, Kozlovskaya MM, Zuikov AV, et al. Effect of Selank on cognitive processes after damage to the catecholaminergic system of the brain in rats. Bull Exp Biol Med. 2007;144(5):689-691. PubMed
4. Ershov FI, Uchakin PN, Ershova ON, et al. Antiviral activity of immunomodulator Selank in experimental influenza infection. Bull Exp Biol Med. 2009;148(9):744-748. PubMed
5. Kozlov SV, Mezentseva MV, Zhurilo NI. Selank and its analogs: effects on gene expression in the hippocampus. Bull Exp Biol Med. 2010;150(1):70-72. PubMed
6. Seredenin SB, Kozlovskaya MM, Blednov YuA, et al. The anxiolytic action of an analog of the endogenous peptide tuftsin on behavior in rats in the Vogel conflict test and elevated plus-maze. Zh Vyssh Nerv Deiat Im I P Pavlova. 1998;48(1):153-160. PubMed
7. Kost NV, Sokolov OY, Gabaeva MV, et al. Serum endogenous opioids and the effect of the anxiolytic selank on the enzymatic degradation of Leu-enkephalin. Bull Exp Biol Med. 2001;132(3):898-901. PubMed